Grundinformationen
- CAS
3663-23-8- Standard-SMILES
CCCCc1ccc(N)c(N)c1- InChIKey
WQEGHHLKDKIWKM-UHFFFAOYSA-N- Summenformel
- C10H16N2
- Durchschnittliche Molmasse
- 164,25 g/mol
- Monoisotopische Masse
- 164,13134851
Namen und Bezeichner
- Bevorzugter Name
- 4-Butyl-1,2-benzenediamine
- IUPAC
- 4-butylbenzene-1,2-diamine
- Lokaler Name
- 4-Butylbenzol-1,2-diamin
- Englischer Name
- 4-butylbenzene-1,2-diamine
- Summenformel
- C10H16N2
- Molmasse
- 164.25
Namen und Synonyme
3663-23-81,2-Benzenediamine, 4-butyl-4-BUTYL-1,2-BENZENEDIAMINE4-n-Butyl-o-phenylenediamineo-Phenylenediamine, 4-butyl-HSDB 62694-butyl-O-phenylenediamine3,4-Diamino-1-butylbenzene4-butyl-1,2-phenylenediamineM4GA1B83X0EINECS 222-917-7DTXSID3063120
Weitere Namen anzeigen
4-Butylbenzol-1,2-diamin4-butylbenzene-1,2-diamine1,2-BENZENEDIAMINE,4-BUTYL-4-butylbenzene-1,2-diamine C10H16N2 164.25
2-AMINO-4-N-BUTYLANILINE4-BUTYL-1,2-BENZENEDIAMINE [HSDB]4nButylophenylenediamine4Butylbenzene1,2diamineoPhenylenediamine, 4butylRefChem:5206191,2Benzenediamine, 4butylDTXCID2039207
Datenbank-Bezeichner
- CAS
3663-23-8- PubChem CID
- 19313
- DTXSID
DTXSID3063120- UNII
- M4GA1B83X0
- EC Number
- 222-917-7
- Nikkaji
- J205.577E
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,1
- Polarare Oberfläche (TPSA)
- 52 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 12
- Formalladung
- 0
- Komplexität
- 125
Experimentelle und physikochemische Eigenschaften
Chemical ClassesNitrogen Compounds -> Amines, Aromatic
Vapor Pressure0.000174 [mmHg]
Physikochemische Eigenschaften
- Schmelzpunkt
- 38 °C · 38 °C
- Siedepunkt
- 302.3 · 302.3±22.0 °C(Predicted)
- Dichte
- 1.027 · 1.027±0.06 g/cm3(Predicted)
- pka
- 4.46 · 4.46±0.10(Predicted)
- EPA chemische Informationen
- 1 · 1,2-Benzenediamine, 4-butyl- (3663-23-8)
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Gefahrenhinweise
Hazards SummaryEmergency treatment: Methemoglobinemia; [HSDB]
Special Reports
EVIDENCE IS GIVEN SUPPORTING TESTING OF THE CLASS OF COMPOUNDS PHENYLENEDIAMINES FOR THEIR TOXIC EFFECTS ON HUMAN HEALTH AND THE ENVIRONMENT. THE RESULTS OF TOXICITY TESTING OF 22 COMPOUNDS ARE TABULATED AS ARE THE EFFECTS FOR WHICH TESTING IS BEING CONSIDERED FOR 13 COMPOUNDS, AND THE USES OR POTENTIAL USES OF 47 PHENYLENEDIAMINES.[UNITED STATES EPA; PHENYLENEDIAMINES; RESPONSE TO INTERAGENCY TESTING COMMITTEE; FED REGIST 47(5) 973 (1982)]
TSCA Requirements
Pursuant to section 8(d) of TSCA, EPA promulgated a model Health and Safety Data Reporting Rule. The section 8(d) model rule requires manufacturers, importers, and processors of listed chemical substances and mixtures to submit to EPA copies and lists of unpublished health and safety studies. 4-Butyl-1,2-benzenediamine is included on this list.
Sicherheit und Schutzausrüstung
Disposal Methods
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Toxikologische Informationen
Adverse EffectsMethemoglobinemia - The presence of increased methemoglobin in the blood; the compound is classified as secondary toxic effect
Regulatorische Informationen
Chemie und Industrie
Verwendung und Herstellung
General Manufacturing Information1,2-Benzenediamine, 4-butyl-: INACTIVE
Anbieter13 Anbieter
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
金瓯生物医药（南京）有限公司13000000000 · [email protected]
郑州阿尔法化工有限公司0371-53778726 18003825608 · [email protected]
ATK CHEMICAL COMPANY LIMITED+undefined-21-51877795 · [email protected]
苏州诺行贸易有限公司0512-65816829 18662214788 · [email protected]
河南利恩化工产品有限公司03716091-9097 13383857418 · [email protected]
南京贝开思医药科技有限公司+86-13912903754 13912903754 · [email protected]
陕西缔都医药有限责任公司81148925 17391631969 · [email protected]
合肥钼凯医药科技有限公司18130062233 · [email protected]
郑州安慕斯化工产品有限公司15981811963 18737195735 · [email protected]
湖北偕丰医药科技有限公司
Zugehörige Reaktionen
5
Notizen zur Verbindung
Wird geladen…